<--- Back to Details
First PageDocument Content
Dopamine agonists / Lysergamides / Adverse drug reaction / Pharmacy / Bromocriptine / Chemistry / Pharmacology / Drug safety / Pharmaceutical sciences
Date: 2015-05-03 23:27:59
Dopamine agonists
Lysergamides
Adverse drug reaction
Pharmacy
Bromocriptine
Chemistry
Pharmacology
Drug safety
Pharmaceutical sciences

Serious adverse drug reactions still occur with bromocriptine

Add to Reading List

Source URL: medicalxpress.com

Download Document from Source Website

File Size: 21,66 KB

Share Document on Facebook

Similar Documents

Pharmaceutical industry / Package insert / Packaging / Insert / Business / Economy

Reference material Standard Workflow for the Revision of Drug Product Package Inserts (Adverse Drug Reaction Reports, etc.)

DocID: 1rsP1 - View Document

Medical research / Pharmaceuticals policy / Health care / Health / Clinical research / Clinical pharmacology / Clinical trials / Drug safety / Pharmacovigilance / Adverse drug reaction / Nonsteroidal anti-inflammatory drug / Yellow Card Scheme

Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad

DocID: 1rcEG - View Document

Pharmaceuticals policy / Clinical research / Clinical pharmacology / Drug safety / World Health Organization / Pharmacovigilance / Uppsala Monitoring Centre / VigiBase / Adverse effect / Adverse drug reaction / Serious adverse event / Adverse event

PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division,

DocID: 1p9e5 - View Document

Medical terminology / Patient safety / Healthcare quality / Clinical pharmacology / Medical ethics / Medical error / Electronic health record / Adverse effect / Adverse event / Never events / Antimicrobial stewardship / Adverse drug reaction

REVIEW ARTICLE A New, Evidence-based Estimate of Patient Harms Associated with Hospital Care John T. James, PhD

DocID: 1p3Uj - View Document

Pharmaceuticals policy / Clinical research / Drug safety / Clinical pharmacology / Healthcare quality / Veterinary Medicines Directorate / Pharmacovigilance / European Medicines Agency / Suspected Adverse Reaction Surveillance Scheme / Adverse effect / Adverse event / National Office of Animal Health

Pharmacovigilance: Monitoring the Safety & Efficacy of Animal Medicines Summary This document

DocID: 1oBM7 - View Document